+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunopathogenesis of lupus and lupus nephritis: recent insights



Immunopathogenesis of lupus and lupus nephritis: recent insights



Current Opinion in Nephrology and Hypertension 11(3): 273-277



Systemic lupus erythematosus is a multisystemic autoimmune disease. The immunopathogenesis is characterized by the loss of tolerance to self. While many abnormalities in the immune system have been detected, genetic factors play a central role in the pathogenesis. The event proximate to target organ involvement appears to be autoantigen-driven, T cell-mediated, B cell activation. High levels of autoantibodies are produced. However, not all autoantibodies are pathogenic to the kidney (i.e. 'nephritogenic'). These nephritogenic autoantibodies appear to share specific physiochemical features that correlate well with patterns of renal injury. While DNA was initially regarded as the inciting autoantigen, this view does not appear to be supported by the prevailing evidence. Nucleosomes, which are structures comprising histones and DNA, have emerged as the more likely candidate autoantigen. Autoantibodies directed against nucleosomes that cross-react with nucleosomal epitopes have been identified. Furthermore, evidence suggests that immunoglobulin-nucleosomal complexes may be important in target organ immune deposition. In-vivo generation of nucleosomes requires apoptosis; in fact, there are several examples of aberrant apoptotic processes that present with autoimmunity. Aberrant apoptosis may also be critical in lupus immunopathogenesis. Indeed, studies on Fas/FasL and Bcl-2 in animal models and in humans have underscored the importance of apoptosis as an etiological factor in lupus. Cytokines, hormonal, infectious and environmental factors have also been found to be important in the pathogenesis of systemic lupus erythematosus. Overall, much progress has been made in elucidating the etiological agents and pathogenic mechanisms by which lupus develops. However, there is still some way to go before arriving at a unifying hypothesis. The reward for a better understanding of lupus immunopathogenesis will be the development of more specific targets for treatment, and the introduction of better and safer treatment modalities.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046337769

Download citation: RISBibTeXText

PMID: 11981256

DOI: 10.1097/00041552-200205000-00002


Related references

Immunopathogenesis of lupus nephritis: new insights from experimental models. Nihon Jinzo Gakkai Shi 37(11): 610-615, 1995

Baseline markers associated with lupus nephritis in patients with recent onset systemic lupus erythematosus. Arthritis and Rheumatism 37(9 Suppl. ): S179, 1994

The immunopathogenesis of lupus nephritis. Advances in Nephrology from the Necker Hospital 6: 119-136, 1976

Immunopathogenesis of lupus nephritis. Contributions to Nephrology 45: 175-180, 1985

MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis. Clinical and Developmental Immunology 2013: 1-13, 2013

MicroRNAs implicated in the immunopathogenesis of lupus nephritis. Clinical and Developmental Immunology 2013: 430239, 2013

Lupus nephritis. Classification, prognosis, immunopathogenesis, and treatment. Rheumatic Diseases Clinics of North America 20(1): 213-242, 1994

Lupus nephritis treated with a cytostatic agent. A case of systemic lupus erythematosus with lupus nephritis treated with 6-mercaptopurine. Danish Medical Bulletin 13(6): 151-154, 1966

Pathogenesis of lupus dermatoses in autoimmune mice. VI. Correlation between positivity of lupus band test and lupus nephritis. Archives of Dermatological Research 278(4): 343-346, 1986

Transition from lupus podocytopathy to diffuse proliferative lupus nephritis without proteinuria in childhood-onset systemic lupus erythematosus. Clinical Nephrology 87(4): 217-219, 2017

Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry. Yonsei Medical Journal 59(7): 857-864, 2018

Presenting features of lupus proliferative glomerulonephritis in European Lupus Clinics Baseline data from the Euro-Lupus Nephritis Trial. Lupus 10(Suppl. 1): S18, 2001

Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients. Journal of Biological Regulators and Homeostatic Agents 29(1): 201-206, 2015

Lupus nephritis: advances in the knowledge of its immunopathogenesis without the expected therapeutic success?. Reumatologia Clinica 9(2): 77-79, 2013

Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Progress in Clinical and Biological Research 337: 301-307, 1990